MAPT and Alzheimer disease: Budding evidence for other CBS biomarkers was provided by the study by Schulz et al. [30] where CBS and AD could be differentiated through fluid biomarkers solely via a combination of nine different proteins: sAPPb, sAPPa, YKL, MCP-1, NfL, P-Tau, T-Tau, a-syn, and Ab42.